|
|
Volumn 63, Issue 15, 2003, Pages 1619-
|
|
Tipranavir: A viewpoint
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPRENAVIR;
LOPINAVIR;
SAQUINAVIR;
TIPRANAVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
PROTEINASE;
PYRIDINE DERIVATIVE;
PYRONE DERIVATIVE;
PROTEINASE INHIBITOR;
RITONAVIR;
CLINICAL TRIAL;
DIARRHEA;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TOLERABILITY;
GASTROINTESTINAL DISEASE;
GENE MUTATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
INSULIN RESISTANCE;
LIPID STORAGE;
NAUSEA;
NOTE;
PHENOTYPE;
SIDE EFFECT;
VIRUS STRAIN;
ANTIBIOTIC RESISTANCE;
DRUG EFFECT;
GENETICS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MUTATION;
CHEMICALLY INDUCED DISORDER;
DRUG POTENTIATION;
HUMAN IMMUNODEFICIENCY VIRUS;
ANTI-HIV AGENTS;
CLINICAL TRIALS;
DRUG RESISTANCE, VIRAL;
HIV INFECTIONS;
HIV PROTEASE;
HIV-1;
HUMANS;
MUTATION;
PYRIDINES;
PYRONES;
DRUG SYNERGISM;
GASTROINTESTINAL DISEASES;
HIV PROTEASE INHIBITORS;
RITONAVIR;
|
|
EID: 0642344501
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-200363150-00010 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
